Phase 3 Clinical Trial for Agitation in Alzheimer's 15-AVP-786-301
Research Grant
Administered By
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
Awarded By
Avanir Pharmaceuticals
Start Date
January 1, 2016
End Date
June 6, 2023
Administered By
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
Awarded By
Avanir Pharmaceuticals
Start Date
January 1, 2016
End Date
June 6, 2023